Zimmerman et al., 1996 - Google Patents
The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4Zimmerman et al., 1996
View HTML- Document ID
- 2326686582630886365
- Author
- Zimmerman L
- De Jesus-Escobar J
- Harland R
- Publication year
- Publication venue
- Cell
External Links
Snippet
Signals released by the Spemann organizer of the amphibian gastrula can directly induce neural tissue from ectoderm and can dorsalize ventral mesoderm to form muscle. The secreted polypeptide noggin mimics these activities and is expressed at the appropriate time …
- 102000008872 noggin protein 0 title abstract description 162
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zimmerman et al. | The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4 | |
Piccolo et al. | Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4 | |
Hsu et al. | The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities | |
Liem et al. | A role for the roof plate and its resident TGFβ-related proteins in neuronal patterning in the dorsal spinal cord | |
Saffell et al. | Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs | |
Shi et al. | Mechanisms of TGF-β signaling from cell membrane to the nucleus | |
Augsburger et al. | BMPs as mediators of roof plate repulsion of commissural neurons | |
Liu et al. | Assigning the positional identity of spinal motor neurons: rostrocaudal patterning of Hox-c expression by FGFs, Gdf11, and retinoids | |
Chang et al. | Xenopus GDF6, a new antagonist of noggin and a partner of BMPs | |
Esteban et al. | The novel Cer-like protein Caronte mediates the establishment of embryonic left–right asymmetry | |
Rebbapragada et al. | Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis | |
Larraín et al. | BMP-binding modules in chordin: a model for signalling regulation in the extracellular space | |
Dale et al. | Cooperation of BMP7 and SHH in the induction of forebrain ventral midline cells by prechordal mesoderm | |
Koppel et al. | A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members | |
Blokzijl et al. | Physical and functional interaction between GATA-3 and Smad3 allows TGF-β regulation of GATA target genes | |
Whitford et al. | Regulation of cortical dendrite development by Slit-Robo interactions | |
Babitt et al. | Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor | |
Kusanagi et al. | Characterization of a bone morphogenetic protein-responsive Smad-binding element | |
Fiori et al. | Dysregulation of the BMP‐p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP) | |
Cattaneo et al. | Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain | |
Hagihara et al. | Neogenin, a receptor for bone morphogenetic proteins | |
Ellies et al. | Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity | |
Wibrand et al. | Identification of genes co‐upregulated with Arc during BDNF‐induced long‐term potentiation in adult rat dentate gyrus in vivo | |
Shah et al. | Misexpression of chick Vg1 in the marginal zone induces primitive streak formation | |
Shou et al. | Opposing effects of bone morphogenetic proteins on neuron production and survival in the olfactory receptor neuron lineage |